INTELLIPHARMACEUTICS INTERNATIONAL INC. — Operating Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/e08c406d-c3b4-415c-bb35-4133bab5c132/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-2.9M | 2021-12-01 – 2022-11-30 | evidence 0001654954-23-008028 |
| FY 2021 | $-4.2M | 2020-12-01 – 2021-11-30 | evidence 0001654954-22-002240 |
| FY 2020 | $-4.7M | 2019-12-01 – 2020-11-30 | evidence 0001654954-21-002166 |
| FY 2019 | $-7.8M | 2018-12-01 – 2019-11-30 | evidence 0001654954-20-002078 |
| FY 2018 | $-13.3M | 2017-12-01 – 2018-11-30 | evidence 0001654954-20-002078 |
| FY 2017 | $-8.3M | 2016-12-01 – 2017-11-30 | evidence 0001654954-20-002078 |
| FY 2016 | — | 2015-12-01 – 2016-11-30 | evidence 0001654954-17-000913 |
| FY 2015 | — | 2014-12-01 – 2015-11-30 | evidence 0001654954-17-000913 |
| FY 2014 | — | 2013-12-01 – 2014-11-30 | evidence 0001654954-17-000913 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
INTELLIPHARMACEUTICS INTERNATIONAL INC. — all facts · Revenue · Net Income